FDA approval of Gardasil to prevent cervical cancer (News-Medical-Net)
The Food and Drug Administration (FDA) has announced the approval of Gardasil, the first vaccine developed to prevent cervical cancer, precancerous genital lesions and genital warts due to human papillomavirus (HPV) types 6, 11, 16 and 18.

FDA approves Gardasil as a treatment for cervical cancer (News-Medical-Net)
Merck & Co. has announced that the U.S. Food and Drug Administration (FDA) approved Gardasil as a treatment for cervical cancer, vulvar and vaginal pre-cancers caused by HPV types 16 and 18 and to prevent low-grade and pre-cancerous lesions and genital warts caused by HPV types 6, 11, 16 and 18.

FDA backs cervical-cancer vaccine (Seattle Times)
The Food and Drug Administration (FDA) on Thursday approved the first vaccine to prevent cervical cancer, the second leading cause of cancer...